Banner - NPPA Connect

NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Opinion|Videos|February 10, 2025

Laser Therapy Protocols in Patients With Melasma and Darker Skin Tones

Author(s)Corey L. Hartman, MD, FAAD

A panelist discusses how using conservative laser settings, proper skin cooling, and careful patient selection is crucial when treating melasma and darker skin types to minimize post-inflammatory hyperpigmentation risks.

Episodes in this series

1 KOL is featured in this series.

EP. 1 Choosing Effective Laser Devices for Improving Skin Tone and Texture

1 KOL is featured in this series.

EP. 2 Comparing Fractional and Non-Fractional Lasers for Skin Rejuvenation

1 KOL is featured in this series.

EP. 3 Deciding When to Use Combination Therapies With Lasers

1 KOL is featured in this series.

EP. 4 Advancements in Laser Safety and Precision for Diverse Skin Types

1 KOL is featured in this series.

EP. 5 Challenges of Rapid Advancements in Laser Technology

1 KOL is featured in this series.

EP. 6 Expanding Laser Benefits for Diverse Patient Populations

EP. 7 Advancing Care With Laser and Light-Based Technology in Dermatology

EP. 7 Advancing Care With Laser and Light-Based Technology in Dermatology

EP. 8 Adjusting Laser Therapy Treatment Based on Patient Access, History, and Motivation

EP. 8 Adjusting Laser Therapy Treatment Based on Patient Access, History, and Motivation

EP. 9 Benefits of a Combination Treatment Approach Using Laser Therapy

EP. 9 Benefits of a Combination Treatment Approach Using Laser Therapy

1 expert is featured in this series.

EP. 10 Using Laser Therapy for Varied Skin Types and Stages of Acne

1 expert is featured in this series.

EP. 11 Laser Therapy as an Alternative or Combination Treatment for Acne

1 expert is featured in this series.

EP. 12 Efficacy and Safety of Laser Treatment for Patients With Acne

1 expert is featured in this series.

EP. 13 Integrated Approaches to Treating Rosacea With Lasers

1 expert is featured in this series.

EP. 14 Managing Expectations and Minimizing Laser Complications

1 expert is featured in this series.

EP. 15 Melanocyte Preservation and Future Directions for Laser Technology

1 expert is featured in this series.

EP. 16 Patient Goals and Outcomes for Treating Pigmentary Issues With Laser Therapy

1 expert is featured in this series.

EP. 17 Laser Therapy Protocols in Patients With Melasma and Darker Skin Tones

1 expert is featured in this series.

EP. 18 Tolerability and Postcare Benefits of Laser Therapy for Patients With Pigmentary Disorders

EP. 19 Tailored Laser and Light-Based Therapies for Acne, Skin of Color, and Inflammatory Conditions

EP. 19 Tailored Laser and Light-Based Therapies for Acne, Skin of Color, and Inflammatory Conditions

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

In-Person Event

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

February 7, 2026

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Trending on Dermatology Times

AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review

Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older

Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis

Introducing Dermatology Times NP/PA Connect

FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA